Epalrestat
50 mg
Eskayef Pharmaceuticals Ltd.
There are no known drug interactions and none well documented.
The most commonly reported adverse reactions include abdominal pain, nausea, rash, itch, erythema and blister.
Pregnancy category is not classified. FDA has not yet classified the drug into a specified pregnancy category
Your urinary color may turn yellowish brown or red due to color of the component of this medicine. Do not worry about the change.
Aldose reductase inhibitor
Keep out of the reach of children. Store away from direct sunlight, heat and moisture.